Trial
NCT04099277
A Study of LY3435151 in Participants With Solid Tumors
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Solid Tumor
Intervention
LY3435151
Why stopped
Study terminated due to strategic business decision by Eli Lilly and Company.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-31